Literature DB >> 21842067

In situ force mapping of mammary gland transformation.

Jose I Lopez1, Inkyung Kang, Weon-Kyoo You, Donald M McDonald, Valerie M Weaver.   

Abstract

Tumor progression is characterized by an incremental stiffening of the tissue. The importance of tissue rigidity to cancer is appreciated, yet the contribution of specific tissue elements to tumor stiffening and their physiological significance remains unclear. We performed high-resolution atomic force microscopy indentation in live and snap-frozen fluorescently labeled mammary tissues to explore the origin of the tissue stiffening associated with mammary tumor development in PyMT mice. The tumor epithelium, the tumor-associated vasculature and the extracellular matrix all contributed to mammary gland stiffening as it transitioned from normal to invasive carcinoma. Consistent with the concept that extracellular matrix stiffness modifies cell tension, we found that isolated transformed mammary epithelial cells were intrinsically stiffer than their normal counterparts but that the malignant epithelium in situ was far stiffer than isolated breast tumor cells. Moreover, using an in situ vitrification approach, we determined that the extracellular matrix adjacent to the epithelium progressively stiffened as tissue evolved from normal through benign to an invasive state. Importantly, we also noted that there was significant mechanical heterogeneity within the transformed tissue both in the epithelium and the tumor-associated neovasculature. The vascular bed within the tumor core was substantially stiffer than the large patent vessels at the invasive front that are surrounded by the stiffest extracellular matrix. These findings clarify the contribution of individual mammary gland tissue elements to the altered biomechanical landscape of cancerous tissues and emphasize the importance of studying cancer cell evolution under conditions that preserve native interactions.

Entities:  

Mesh:

Year:  2011        PMID: 21842067      PMCID: PMC3564969          DOI: 10.1039/c1ib00043h

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  79 in total

Review 1.  Management of ductal carcinoma in situ.

Authors:  E S Hwang; L J Esserman
Journal:  Surg Clin North Am       Date:  1999-10       Impact factor: 2.741

2.  Cancer cell stiffness: integrated roles of three-dimensional matrix stiffness and transforming potential.

Authors:  Erin L Baker; Jing Lu; Dihua Yu; Roger T Bonnecaze; Muhammad H Zaman
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

3.  Significant differentiation of focal breast lesions: calculation of strain ratio in breast sonoelastography.

Authors:  Anke Thomas; Friedrich Degenhardt; André Farrokh; Sebastian Wojcinski; Torsten Slowinski; Thomas Fischer
Journal:  Acad Radiol       Date:  2010-02-20       Impact factor: 3.173

4.  Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.

Authors:  Feng-Ju Huang; Weon-Kyoo You; Paolo Bonaldo; Thomas N Seyfried; Elena B Pasquale; William B Stallcup
Journal:  Dev Biol       Date:  2010-06-27       Impact factor: 3.582

Review 5.  Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models.

Authors:  Dai Fukumura; Dan G Duda; Lance L Munn; Rakesh K Jain
Journal:  Microcirculation       Date:  2010-04       Impact factor: 2.628

6.  Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness.

Authors:  Vincente Pedraza; Jose A Gomez-Capilla; Georgia Escaramis; Carolina Gomez; Pablo Torné; Jose M Rivera; Angel Gil; Patricia Araque; Nicolas Olea; Xavier Estivill; M Esther Fárez-Vidal
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

7.  Ricinus communis agglutinin I leads to rapid down-regulation of VEGFR-2 and endothelial cell apoptosis in tumor blood vessels.

Authors:  Weon-Kyoo You; Ian Kasman; Dana D Hu-Lowe; Donald M McDonald
Journal:  Am J Pathol       Date:  2010-02-25       Impact factor: 4.307

Review 8.  Matrix metalloproteinases: regulators of the tumor microenvironment.

Authors:  Kai Kessenbrock; Vicki Plaks; Zena Werb
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

9.  Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation.

Authors:  M A Swartz; A Kaipainen; P A Netti; C Brekken; Y Boucher; A J Grodzinsky; R K Jain
Journal:  J Biomech       Date:  1999-12       Impact factor: 2.712

10.  Harnessing traction-mediated manipulation of the cell/matrix interface to control stem-cell fate.

Authors:  Nathaniel Huebsch; Praveen R Arany; Angelo S Mao; Dmitry Shvartsman; Omar A Ali; Sidi A Bencherif; José Rivera-Feliciano; David J Mooney
Journal:  Nat Mater       Date:  2010-04-25       Impact factor: 43.841

View more
  112 in total

1.  Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha.

Authors:  Seema S Desai; Jason C Tung; Vivian X Zhou; James P Grenert; Yann Malato; Milad Rezvani; Regina Español-Suñer; Holger Willenbring; Valerie M Weaver; Tammy T Chang
Journal:  Hepatology       Date:  2016-03-09       Impact factor: 17.425

Review 2.  Quantitative analysis of gradient sensing: towards building predictive models of chemotaxis in cancer.

Authors:  Shannon K Hughes-Alford; Douglas A Lauffenburger
Journal:  Curr Opin Cell Biol       Date:  2012-01-26       Impact factor: 8.382

3.  Genome variation across cancers scales with tissue stiffness - an invasion-mutation mechanism and implications for immune cell infiltration.

Authors:  Charlotte R Pfeifer; Cory M Alvey; Jerome Irianto; Dennis E Discher
Journal:  Curr Opin Syst Biol       Date:  2017-04-27

4.  Endothelial matrix assembly during capillary morphogenesis: insights from chimeric TagRFP-fibronectin matrix.

Authors:  Fumin Chang; Christopher A Lemmon; Voraphoj Nilaratanakul; Varda Rotter; Lewis Romer
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

5.  Matrix stiffening promotes a tumor vasculature phenotype.

Authors:  Francois Bordeleau; Brooke N Mason; Emmanuel Macklin Lollis; Michael Mazzola; Matthew R Zanotelli; Sahana Somasegar; Joseph P Califano; Christine Montague; Danielle J LaValley; John Huynh; Nuria Mencia-Trinchant; Yashira L Negrón Abril; Duane C Hassane; Lawrence J Bonassar; Jonathan T Butcher; Robert S Weiss; Cynthia A Reinhart-King
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-29       Impact factor: 11.205

6.  Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer.

Authors:  Fernando Salvador; Alberto Martin; Celia López-Menéndez; Gema Moreno-Bueno; Vanesa Santos; Alberto Vázquez-Naharro; Patricia G Santamaria; Saleta Morales; Pierre R Dubus; Laura Muinelo-Romay; Rafael López-López; Jason C Tung; Valerie M Weaver; Francisco Portillo; Amparo Cano
Journal:  Cancer Res       Date:  2017-07-18       Impact factor: 12.701

7.  Microfabricated collagen tracks facilitate single cell metastatic invasion in 3D.

Authors:  Casey M Kraning-Rush; Shawn P Carey; Marsha C Lampi; Cynthia A Reinhart-King
Journal:  Integr Biol (Camb)       Date:  2013-03       Impact factor: 2.192

8.  Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior.

Authors:  Brooke N Mason; Alina Starchenko; Rebecca M Williams; Lawrence J Bonassar; Cynthia A Reinhart-King
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

Review 9.  Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression.

Authors:  Scott Gehler; Suzanne M Ponik; Kristin M Riching; Patricia J Keely
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2013       Impact factor: 1.807

10.  TGF-β upregulates miR-181a expression to promote breast cancer metastasis.

Authors:  Molly A Taylor; Khalid Sossey-Alaoui; Cheryl L Thompson; David Danielpour; William P Schiemann
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.